Abivax S.A. - Ordinary Shares, par value EUR0.01 per share (ABVX)

CUSIP: 00370M103

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
+21,308,910
Put/Call ratio
69%
SEC-reported price per share
$84.90
Number of holders
165
Value change
+$2,126,922,733
Number of buys
145
Open additional details 1 more signal available
Number of sells
24
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
82,081,761

Security key

00370M103

Report period

Q3 2025

Institutions

165

Top holders

10

Ownership snapshot

Top reported holders of ABVX - Abivax S.A. - Ordinary Shares, par value EUR0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TCG Crossover GP I, LLC
Disclosed value leader
TCG Crossover GP I, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F Lead comparable stake: 9.1% 13D/G row: TCG Crossover GP I, LLC Showing 1-6 of 15 holder rows.

Quick read

TCG Crossover GP I, LLC leads the comparable SEC ownership view at 9.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TCG Crossover GP I, LLC's linked filing trail.
Comparable ownership Top 5
TCG Crossover GP I, LLC 9.1%
Deep Track Capital, LP 4.8%
Venrock Healthcare Capital Partne... 0.8%
TCG Crossover Management, LLC 7.4%
ADAR1 Capital Management, LLC 3.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TCG Crossover GP I, LLC
13D/G
Chen Yu
9.1%
$603,774,500
7,111,596 shares
$0 30 Sep 2025
Deep Track Capital, LP
13D/G 13F
Company
4.8%
$28,885,195
3,480,144 shares
$0 30 Jun 2025
Venrock Healthcare Capital Partners III, L.P.
13D/G
0.8%
$48,964,292
576,729 shares
$0 30 Sep 2025
TCG Crossover Management, LLC
13F
Company
13F
7.4%
$46,332,959
6,056,596 shares
30 Jun 2025
ADAR1 Capital Management, LLC
13F
Company
13F
3.7%
$23,495,751
3,071,340 shares
30 Jun 2025
Cormorant Asset Management, LP
13F
Company
13F
2.6%
$16,294,500
2,130,000 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
165
Shares
51,964,814
Rows available
165
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
43
Q3 2025 holders
165
Holder diff
122
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .